文献速递神经眼科

美国视神经炎住院患者血浆置换使用趋势

Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States.
PubMed 文献 · Ophthalmology · 2024-03-27

该回顾性横断面研究基于美国全国住院患者样本数据库,分析2000至2020年因视神经炎住院的成年患者中血浆置换(PLEX)的使用趋势及与PLEX相关的社会人口学和医学合并症。结果显示PLEX使用率从0.63%稳步上升至5.46%,西部使用最多、东部最少;在ICD-10病例亚组中,PLEX中位治疗时间为入院后1天,视神经脊髓炎谱系疾病(NMOSD)患者使用率最高(21.21%),多发性硬化相关视神经炎最低(3.80%),PLEX使用与更长的住院时间和更高的总费用相关。

要点

  • 2000至2020年美国因视神经炎住院患者中,PLEX使用率从0.63%上升至5.46%。
  • 在ICD-10病例亚组中,NMOSD患者PLEX使用率最高(21.21%),多发性硬化相关视神经炎最低(3.80%)。
  • PLEX使用与更长的住院时间和更高的总费用相关。

核心结论

  • 过去20年美国视神经炎住院患者中PLEX治疗使用增加,西部使用最多,NMOSD相关视神经炎患者使用率最高。

研究设计与样本

  • 回顾性横断面研究,数据来自美国全国住院患者样本数据库,纳入2000至2020年因视神经炎主要诊断住院的成年患者(≥18岁),共识别11 209例。

主要发现

  • 2000至2020年共识别11 209例因视神经炎主要诊断住院的患者,其中绝大多数在城市教学医院管理。
  • PLEX使用率在20年间从0.63%稳步上升至5.46%,美国西部使用最多、东部最少。
  • 在ICD-10病例亚组中识别3215例患者,PLEX中位治疗时间为入院后1天,NMOSD患者使用率最高(21.21%),多发性硬化相关视神经炎最低(3.80%)。
  • PLEX使用与显著更长的住院时间和更高的总费用相关。

关键数值与推荐

  • 与PLEX相关的医学合并症包括:糖皮质激素不良反应(aOR 31.50)、偏瘫(aOR 28.48)、神经痛(aOR 4.81)、视神经萎缩(aOR 3.74)、麻痹性斜视(aOR 2.36)、银屑病(aOR 1.76)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report use trends of plasma exchange (PLEX) as well as sociodemographic and medical comorbidities associated with PLEX in the United States. DESIGN: Retrospective cross-sectional study. PARTICIPANTS: Adult patients (≥ 18 years) admitted for inpatient hospitalization with a primary diagnosis of optic neuritis (ON). METHODS: Data from the National Inpatient Sample database was compiled to assess PLEX use rates between 2000 and 2020. The cohorts of patients receiving PLEX versus not receiving PLEX were analyzed between quarter 4 of 2015 through 2020 (International Classification of Diseases, Tenth Revision [ICD-10], only) for patient sociodemographic variables, medical diagnoses, insurance types, hospital characteristics, cause of disease, time to therapy, length of stay (LOS), and total charges incurred. MAIN OUTCOME MEASURES: Incidence of ON, incidence of PLEX, demographics, diagnoses associated with PLEX therapy, total charges, and LOS. RESULTS: From 2000 through 2020, 11 209 patients hospitalized with a primary diagnosis of ON were identified, with a significant majority managed at urban teaching hospitals. Use of PLEX increased steadily over 2 decades from 0.63% to 5.46%. Use was greatest in the western United States and least in the eastern United States. In the subset of ICD-10 cases, 3215 patients were identified. The median time to therapy of PLEX was 1 day after admission, and PLEX use was highest in patients with neuromyelitis optica spectrum disorder (NMOSD) (21.21%) and lowest in multiple sclerosis-associated ON (3.80%). Use of PLEX was associated with significantly longer LOS and higher total charges incurred. Medical comorbidities associated with PLEX included adverse reaction to glucocorticoids (adjusted odds ratio [aOR], 31.50), hemiplegia (aOR, 28.48), neuralgia (aOR, 4.81), optic atrophy (aOR, 3.74), paralytic strabismus (aOR, 2.36), and psoriasis (aOR, 1.76). CONCLUSIONS: Over the last 2 decades in the United States, PLEX therapy for ON has increased, with the highest use in the western United States and for patients with the diagnosis NMOSD ON. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Akosman S, Li R, Asahi M, et al. Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States. Ophthalmology. 2024. PMID: 38552677. doi:10.1016/j.ophtha.2024.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。